Read the story about Boehringer Ingelheim's first biotech facility in Asia , which is based on NNE’s Bio on demand™ concept for flexible facility design.
Beijing Fresenius Pharmaceutical needed to establish a new compliant pharma production facility. Read how NNE helped ensure full GMP compliance.
Read how NNE’s local biotech pharma know-how came in handy when we helped Novozymes build an industrial biotech plant for cost-effective enzyme production.
Read the story about NNE’s long-term commitment in the expansion of Sanofi Pasteur’s GMP manufacturing facility for vaccines in Shenzhen, China.
PT Widatra Bhakti built a new large volume parenterals facility based on NNE’s facility design. Read about the fast-track project.
Read how our pharmaceutical plant design helped PT Widatra Bhakti meet its capacity problems and new authority requirements.
Read why ZMC Ltd. chose NNE as its engineering partner for its first biotech manufacturing plant in China.
Read about the optimization of one of the world’s largest enzyme fermentation plants – Novozymes’ industrial biotechnology facility in Hongda, China.
NNE challenged Junshi to choose a modular facility design. Read how this lead to high flexibility in Junshi's large-scale biotech plant.
Supported by NNE, Novozymes built a new facility for solid state fermentation of enzymes in India. Read more about the large supply chain consolidation project.